Glass molded vials: new partnership between Stevanato Group and Bormioli Pharma

Stevanato Group, through Ompi, its specialist in glass primary packaging for the pharmaceutical industry, and Bormioli Pharma announce today a collaboration agreement. The agreement will enable biopharma customers, contract filling organizations, and research laboratories to receive Bormioli Pharma’s proprietary primary containers in Ompi’s industry-recognized EZ-fill® secondary packaging configuration.

Bormioli Pharma glass vials supplied in Ompi’s packaging configurations can be processed into existing fill-finish lines. EZ-fill® secondary packaging is designed to mitigate the risk of breakages, cosmetic issues, and particulate generation. It is the ideal solution from lab-scale manual filling up to the traditional filling process, allowing to accelerate the commercialization of pharmaceutical and biologics.

Andrea Sentimenti, Marketing&Innovation Manager at Bormioli Pharma said: “The agreement with Stevanato Group is one more step forward in this direction and allows us to combine the high quality of our parenteral vials with the reliability of EZ-fill® technology. The result is a premium packaging solution for parenteral drugs, engineered to overcome the challenges of the most demanding injectables”.

All rights reserved except agreement written by Emballage Digest or mention of the magazine